Lunch & Learn: Adopting Strategies that Successfully Impact Drug Development Programs Including Rare Diseases

Thursday 13 October 2022, 11.00-13.00

Registration is now closed for tomorrow's Lunch & Learn event. If you would like to attend, please contact jasmin@onenucleus.com.

This session, facilitated by Zizi Imatorbhebhe, Senior Vice President, Global Strategy & Development, Rare Disease, Head Rare Disease Innovation Center at Ergomed, will cover: 

  • The big challenges facing Drug Development including Rare Diseases 
  • What small biotechnology companies need to keep in mind when embarking on a drug development program
  • How to leverage Ergomed's Rare Disease innovation center to accelerate your drug development program

 

Meet Zizi: 

 

This event is free to attend.

Please note, anyone registering will be subject to approval by the sponsor and may have their registration cancelled. You will be informed whether your registration has been approved or cancelled within 2 working days of registering online for the event. 

By registering for this event you consent to your contact details to be shared with Ergomed and may be used by Ergomed for sending you additional marketing and business development-related information. You can withdraw your consent at any time at info@ergomedplc.com, and your personal data held by Ergomed will be erased. Please visit the Ergomed website's data policy section for more information about their privacy policy and your rights.

 

 

When
October 13th, 2022 from 11:00 AM to  1:00 PM
Location
Kings Hedges Room
The Babraham Research Campus
Babraham
Cambridge, Cambridgeshire CB22 3AT
United Kingdom
Contact
Phone: 01223 896450
Phone: 01223 896456